| Michael Repine, MD | |
|
2750 Broadway St, Boulder, CO 80304-3573 | |
| (303) 440-3000 | |
| Not Available |
| Full Name | Michael Repine |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 2750 Broadway St, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316921919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 37298 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Medical Center, Pc | 4183536204 | 79 |
| Select Physical Therapy Of West Denver Limited Partnership | 6709771157 | 124 |
News Archive
A New York state law passed in the 1980s prevents the state from implementing CDC's revised recommendations on HIV testing in the U.S. that say HIV tests should become a routine part of medical care for residents ages 13 to 64 and that requirements for written consent and pretest counseling should be dropped, the New York Times reports.
A recent case study by doctors at Mount Sinai Hospital in New York examined the ethical issues posed by transplant tourism, an offshoot of medical tourism, which focuses solely on transplantation surgery. Many American transplant professionals frown on the practice of transplant tourism where patients travel to countries such as China, India, and the Philippines for their transplantation.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
› Verified 7 days ago
| Entity Name | Boulder Medical Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306820923 PECOS PAC ID: 4183536204 Enrollment ID: O20031105000512 |
News Archive
A New York state law passed in the 1980s prevents the state from implementing CDC's revised recommendations on HIV testing in the U.S. that say HIV tests should become a routine part of medical care for residents ages 13 to 64 and that requirements for written consent and pretest counseling should be dropped, the New York Times reports.
A recent case study by doctors at Mount Sinai Hospital in New York examined the ethical issues posed by transplant tourism, an offshoot of medical tourism, which focuses solely on transplantation surgery. Many American transplant professionals frown on the practice of transplant tourism where patients travel to countries such as China, India, and the Philippines for their transplantation.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Repine, MD 2750 Broadway St, Boulder, CO 80304-3573 Ph: (303) 440-3000 | Michael Repine, MD 2750 Broadway St, Boulder, CO 80304-3573 Ph: (303) 440-3000 |
News Archive
A New York state law passed in the 1980s prevents the state from implementing CDC's revised recommendations on HIV testing in the U.S. that say HIV tests should become a routine part of medical care for residents ages 13 to 64 and that requirements for written consent and pretest counseling should be dropped, the New York Times reports.
A recent case study by doctors at Mount Sinai Hospital in New York examined the ethical issues posed by transplant tourism, an offshoot of medical tourism, which focuses solely on transplantation surgery. Many American transplant professionals frown on the practice of transplant tourism where patients travel to countries such as China, India, and the Philippines for their transplantation.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
› Verified 7 days ago
Jennah Mann, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2150 Stadium Dr 2nd Floor, Boulder, CO 80309 Phone: 720-848-0000 | |
William C. Kramer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-5821 | |
Dr. Stephen D Paul, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-2730 | |
Dr. James B Rector, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2790 Fax: 303-449-5821 | |
Brian Patrick Davis, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 | |
Robert A Harper, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 | |
Dirk Dolbeare, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-5821 |